Acceleron Pharma Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $93 M for Acceleron Pharma Inc. in the year to December 2020.
- Both made a net loss: $166 M for Acceleron Pharma Inc. and $2.8 B for Moderna, Inc.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -179.5% for Acceleron Pharma Inc.
- Moderna, Inc. employs more people: 4,700 against 225 at Acceleron Pharma Inc. Each employee brings in about $411,200 of revenue at Acceleron Pharma Inc. and $413,617 at Moderna, Inc.
Market cap history
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Acceleron Pharma Inc. XLRN | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2003 | 2010 |
| Size | ||
| Market cap | — | $90.1 B |
| Revenue | $93 M | $1.9 B |
| Net income | $-166 M▲ best | $-2.8 B |
| Employees | 225 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap — | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which makes more money, Acceleron Pharma Inc. or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $93 M for Acceleron Pharma Inc. in the year to December 2020. Both made a net loss: $166 M for Acceleron Pharma Inc. and $2.8 B for Moderna, Inc.
Which is more profitable, Acceleron Pharma Inc. or Moderna, Inc.?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -179.5% for Acceleron Pharma Inc.
Which has more employees, Acceleron Pharma Inc. or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 225 at Acceleron Pharma Inc. Each employee brings in about $411,200 of revenue at Acceleron Pharma Inc. and $413,617 at Moderna, Inc.
More about Acceleron Pharma Inc.
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.